Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Sonoma Pharmaceuticals, Inc. (SNOA)
Standardized SEC financial data for Sonoma Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001367083 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$17.9M
$18.6M
$12.6M
$13.3M
$12.7M
$14.3M
Cost of revenue
$9.8M
$12.1M
$8.6M
$8.8M
$8.0M
$8.8M
Gross profit
$8.1M
$6.6M
$4.0M
$4.5M
$4.7M
$5.5M
R&D expense
$1.3M
$555K
$125K
$207K
$1.9M
$1.8M
SG&A expense
$14.2M
$9.5M
$9.8M
$8.8M
$7.6M
$7.4M
Operating income
-$7.4M
-$3.4M
-$5.9M
-$4.6M
-$4.7M
-$3.7M
EBITDA
-$7.1M
-$3.2M
-$5.7M
-$4.4M
-$4.5M
-$3.6M
Interest expense
$16K
$12K
$24K
$17K
$22K
$11K
Pretax income
-$3.5M
-$3.9M
-$5.4M
-$5.2M
-$5.0M
-$2.9M
Income tax
$29K
$713K
$332K
$33K
$196K
$550K
Net income
-$3.3M
-$4.0M
-$5.1M
-$5.2M
-$4.8M
-$3.5M
EPS (diluted)
—
—
$-38.40
$-30.40
$-10.63
$-2.79
Standardized from Sonoma Pharmaceuticals, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.